Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, August 28, 2014
 
Register | Sign in
Home Page>Products
  Product News
Cresset Announces the Release of Forge V10.3
Tuesday, July 08, 2014
Significant new science, visualization and integration for leading ligand-based drug design workbench.

BioTek Launches Enhanced SiLA Compliant Software
Tuesday, July 08, 2014
BioTek’s LHC™ SiLA software for washers/dispensers.

BioTek Launches Enhanced SiLA Compliant Software
Tuesday, July 08, 2014
BioTek’s LHC™ SiLA software for washers/dispensers.

Revolutionary Transfer Tool for Automated Nested LiHa Disposable Tip Handling
Tuesday, July 08, 2014
The device from Tecan offers increased throughput and capacity for Freedom EVO® workstations.

Zetasizer Helix Combines Dynamic Light Scattering and Raman Spectroscopy for Advanced Protein Structure Analysis
Tuesday, July 08, 2014
The new Zetasizer Helix from Malvern Instruments is a powerful tool for early stage biopharmaceutical development that enables the detailed study of mechanisms of protein aggregation.

Method Separates Oxidized Monoclonal Antibody (MAb) Species
Friday, July 04, 2014
Thermo Scientific™ ProPac™ HIC-10 column used to separate the papain fragments.

Bioo Scientific Launches NEXTflex Cell Free DNA-Seq Kit
Friday, July 04, 2014
Optimized for ctDNA and cfDNA library preparation.

Schleicher GRED® Software from Schleicher Electronic
Friday, July 04, 2014
A new and unique type of software for retained data.

Analytik Announces the Release of New Agilent 4300 Handheld FTIR
Thursday, July 03, 2014
Now available in the UK and Ireland.

<< 10 11 12 13 14 15 16 >>
Showing Results 121 - 130 of 10424
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv